Threonine
Who holds supplier records for Threonine? 7 organisations hold a current record for Threonine: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Japan (2), Germany (1), United States (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Threonine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/threonine
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Threonine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AMINO GMBHGermanyCEP Company GMP cert on recordActive DMF 34526 · latest filing Mar 2020
- AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INCUnited StatesActive DMF 31564 · latest filing Mar 2017
- SHANGHAI AJINOMOTO AMINO ACID CO LTDChinaActive DMF 29306 · latest filing Apr 2015
- JapanCEP Company GMP cert on record
- FranceCEP Company GMP cert on record
- JapanCEP
- Shanghai Plumino Amino Acid Co.,Ltd.ChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Threonine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| AJINOMOTO CO., INC. Chuo-Ku | JP | CEP 2014-204 - Rev 02 Threonine, L-Threonine II | Aug 2026 | — |
| EVONIK REXIM S.A.S. Ham | FR | CEP 2004-310 - Rev 03 Threonine, Fermentation origin | Jul 2026 | Inspected Mar 2024 France |
| SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai | CN | CEP 2010-044 - Rev 01 Threonine | Sept 2025 | Inspected Mar 2024 Germany |
| AMINO GMBH Frellstedt | DE | R1-CEP 2004-277 - Rev 03 Threonine | Aug 2023 | — |
| KYOWA HAKKO BIO CO., LTD. Tokyo | JP | R1-CEP 1999-015 - Rev 02 Threonine | Jul 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Threonine are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- TANABE SEIYAKU CO LTDInactive DMF 1248, 10061 · filed Jan 1993
- SIGMA F AND D DIV LTDInactive DMF 9992 · filed Nov 1992
- DEGUSSA AG WERK RADEBEULInactive DMF 3973 · filed May 1980
Overview
Threonine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL291747).
Chemical identity
- IUPAC name
- (2S,3R)-2-amino-3-hydroxybutanoic acid
- Canonical SMILES
- C[C@H]([C@@H](C(=O)O)N)O
- InChIKey
- AYFVYJQAPQTCCC-GBXIJSLDSA-N
- Synonyms
- FEMA NO. 4710, L-threonine, NSC-16589, NSC-46701, Threonine, Treonina, (2S,3R)-2-amino-3-hydroxybutanoic acid, Threonin, L-(-)-Threonine, (S)-Threonine, 2-amino-3-hydroxybutyric acid, (2S,3R)-2-Amino-3-hydroxybutyric acid
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Threonine?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Threonine: AMINO GMBH (Germany), AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INC (United States), SHANGHAI AJINOMOTO AMINO ACID CO LTD (China), AJINOMOTO CO INC (Japan), EVONIK REXIM SAS (France), Kyowa Hakko Bio Co., Ltd. (Japan) and Shanghai Plumino Amino Acid Co.,Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Threonine Drug Master Files are active?
AMINO GMBH (DMF 34526), AJINOMOTO HEALTH AND NUTRITION NORTH AMERICA INC (DMF 31564) and SHANGHAI AJINOMOTO AMINO ACID CO LTD (DMF 29306). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Threonine records mean?
3 organisations have only inactive Type II DMFs for Threonine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Threonine have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Threonine on the EDQM register, including AJINOMOTO CO., INC. Chuo-Ku (JP), EVONIK REXIM S.A.S. Ham (FR), SHANGHAI PLUMINO AMINO ACID CO., LTD. Shanghai (CN), AMINO GMBH Frellstedt (DE) and KYOWA HAKKO BIO CO., LTD. Tokyo (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Threonine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Threonine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.